BioSpace News Archive

Drug Development

Verseon to Initiate Phase I Study to Evaluate a New Precision Oral Anticoagulant with Reduced Bleeding Risk

First-in-human phase I trial in Australia for its lead-PROAC VE-1902, which has successfully completed regulatory toxicology studies and was well-tolerated in 28-day repeat dosing.

June 14, 2018
·
3 min read
Business

Tilak Announces CE Marking for Odysight, Its First Mobile Medical Game in Ophthalmology

Tilak announced that Odysight, its first mobile medical game dedicated to the monitoring of patients with chronic eye diseases, has achieved CE marking.

June 14, 2018
·
3 min read
Biotech Bay

Mindstrong Health Announces $15M Series B Round Financing and Business Update

Round includes new investor Bezos Expeditions and Decheng Capital with Series A investors Optum Ventures, ARCH Venture Partners and Foresite Capital

June 14, 2018
·
3 min read
Business

Cheetah Medical’s French Distributor SEBAC SA to Supply Starling SV Monitoring Systems to Paris’ Public Hospital System

The four-year deal calls for the Starling SV Hemodynamic Monitoring System to be installed in more than 40 hospitals around Greater Paris.

June 14, 2018
·
3 min read
Policy

The Final Countdown in Hi-Tech Pharmaceuticals Fight for DMAA

A key issue in this case is whether the substance 1,3-Dimethylamylamine HCL (“DMAA”) is a naturally occurring constituent of the geranium plant.

June 14, 2018
·
6 min read
Job Trends

Quick Hip Replacement Corrects Fortysomething’s “Pirate Walk”

Pain in Mindy Shufelt’s hip began several years ago and slowly got worse.

June 14, 2018
·
2 min read
BioForest

Increasing Automation of Claims-Related Business Transactions Would Save Healthcare $11.1 Billion Annually

Healthcare Providers Would Gain Greatest Share of Savings -- $9.5 Billion

June 14, 2018
·
5 min read
Drug Development

Apexigen and Yale Cancer Center Announce Clinical Collaboration to Evaluate APX005M, Cabiralizumab, and Opdivo (Nivolumab) in Patients whose Disease has Progressed on Anti-PD-1/PD-L1 Therapy

Phase 1/2 clinical trial in patients with advanced solid tumors that have progressed on anti-PD-1/PD-L1 therapy to evaluate APX005M in combination with cabiralizumab and Opdivo

June 14, 2018
·
3 min read
Pharm Country

Phreesia Named to the 2018 Healthcare Informatics 100 List

Phreesia announced it has been named to the Healthcare Informatics 100,

June 14, 2018
·
1 min read
Policy

OTC Markets Group Welcomes The Green Organic Dutchman Holdings Ltd. to OTCQX

OTC Markets Group Inc. announced The Green Organic Dutchman Holdings Ltd. has qualified to trade on the OTCQX® Best Market.

June 14, 2018
·
3 min read